BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2968990)

  • 1. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin.
    Grefberg N; Danielson BG; Berne C
    J Diabet Complications; 1987; 1(1):16-9. PubMed ID: 2968990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
    Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
    Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
    Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
    Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
    Perit Dial Int; 1996; 16 Suppl 1():S288-91. PubMed ID: 8728209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
    Triolo G; Carta Q; Salomone M; Dani F; Passarino G; Boggio Bertinet D; Segoloni GP; Vercellone A
    Life Support Syst; 1983; 1 Suppl 1():454-6. PubMed ID: 6400733
    [No Abstract]   [Full Text] [Related]  

  • 7. Administration of insulin by continuous ambulatory peritoneal dialysis.
    Chan E; Montgomery PA
    Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advisability of switching of i.p. insulin in to CAPD.
    Quellhorst E
    Semin Dial; 2002; 15(5):376. PubMed ID: 12358646
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A
    Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of two different routes for insulin administration in CAPD diabetic patients. A multicenter study.
    Selgas R; Diez JJ; Muñoz J; Miranda B; de Alvaro F; Rodriguez JC
    Adv Perit Dial; 1989; 5():181-4. PubMed ID: 2577407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
    Tzamaloukas AH; Oreopoulos DG
    Adv Perit Dial; 1991; 7():81-5. PubMed ID: 1680463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic subcapsular steatosis in diabetic CAPD patients treated with intraperitoneal insulin. Description of a typical pattern.
    Kallio T; Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
    Acta Radiol; 2001 May; 42(3):323-5. PubMed ID: 11350293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRD.
    Flynn JT; Kershaw DB; Sedman AB; Smoyer WE; Bunchman TE
    Adv Perit Dial; 1998; 14():265-8. PubMed ID: 10649738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal insulin: new alternative for diabetic CAPD patients.
    Bandel-Walcer R; Myers C; Malgaonkar S; Lyman N
    AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
    Riambau E; Aubia J; Llorach I; Lloveras J; Masramón J; Orfila A; Llorach M
    Rev Clin Esp; 1982 Mar; 164(5):333-4. PubMed ID: 7048442
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraperitoneal insulin in diabetic CAPD patients.
    Mactier RA; Khanna R
    Int J Artif Organs; 1988 Jan; 11(1):9-12. PubMed ID: 3283057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.